Ethyl 5-[(1H-benzoimidazol-2-yl)amino­carbon­yl]-4-hydr­oxy-2-methyl-6-oxo-1-propyl-1,6-dihydro­pyridine-3-carboxyl­ate–ethanol–methanol (4/2/1)

The asymmetric unit of the title compound, 4C(20)H(22)N(4)O(5)·2C(2)H(6)O·CH(4)O, contains two pyridine-3-carboxyl­ate mol­ecules, one ethanol mol­ecule and one methanol mol­ecule disordered about in a centre of symmetry. The pyridinone ring, the carbamide group and the bicyclic fragment in both independent mol­ecules are planar within 0.03 Å due to the formation of intra­molecular O—H⋯O and N—H⋯O hydrogen bonds. The formation of these latter inter­actions also causes the redistribution of the electron density within the hydroxy­pyridone fragment, with the result that some bonds are elongated compared with values in the literature and some others are shorter. In the crystal phase, the pyridine-3-carboxyl­ate mol­ecules form layers parallel to (010), which are inter­linked through hydrogen bonds mediated by the bridging solvate mol­ecules. A terminal ethyl group in one of the mol­ecules is disordered over two sites of equally occupancy.